Johnson & Johnson Invests in Vietnam Healthcare Training

Why this is here: Johnson & Johnson plans to train around 10,000 healthcare workers in Vietnam over the next two years, concentrating on areas like oncology and hematology.

Patkie of Johnson & Johnson Innovative Medicine asserts that healthcare functions as a key economic driver in Vietnam. The company views health as a strategic investment capable of supporting the country’s long-term development goals, aligning with Resolution 72 issued in September 2025. Currently, Vietnam allocates roughly 5% of its GDP to healthcare, compared to the global average of around 10%.

Johnson & Johnson is collaborating with hospitals like Ho Chi Minh City Oncology Hospital and K Hospital to improve diagnostic capabilities and referral systems. They aim to train approximately 10,000 healthcare workers over the next two years, focusing on oncology, hematology, and dermatology. GLOBOCAN 2022 data shows over 24,000 new lung cancer cases in Vietnam, with nearly 75% diagnosed late-stage.

However, challenges remain in early detection, particularly for cancers like multiple myeloma where over 50% of cases are found in advanced stages. Johnson & Johnson acknowledges the need for systemic solutions, not just individual case management, to address these issues and improve patient outcomes. The work to improve access and training will continue.